Protocol to Obtain Blood Samples for Leukemia Research



Status:Active, not recruiting
Conditions:Blood Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:3/8/2019
Start Date:April 2009
End Date:April 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to collect a blood sample in patients with Chronic Lymphocytic
Leukemia (CLL).

The blood sample will be used in the laboratory to perform studies focusing on Chronic
Lymphocytic Leukemia (CLL).

Inclusion Criteria:

- Patients undergoing routine blood draws as part of their ongoing follow-up for Chronic
Lymphocytic Leukemia (CLL) at the Norris Cotton Cancer Center of DHMC.

Exclusion Criteria:

- Patients who have received cytotoxic drug, oral or intravenous steroid or targeted
antibody therapy for CLL or other disease process within the past 6 months are
excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.
We found this trial at
1
site
Dartmouth Hitchcock Medical Center
1 Medical Center Dr
Lebanon, New Hampshire 03756
 (603) 650-5000
Principal Investigator: Christopher H Lowrey
Phone: 800-639-6918
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
?
mi
from
Lebanon, NH
Click here to add this to my saved trials